Looking Beyond CNS, SK Biopharm Begins First US Oncology Trial

Aims To Double Business This Year

 
• By Jung Won Shin
  
Jeong Woo Cho, CEO Of SK Biopharmaceuticals
M&A Also On The Table To Accelerate Product Launches • Source: SK Biopharmaceuticals Co. Ltd.

More from South Korea

More from Focus On Asia